Company page
Sk Biopharmaceuticals Co., Ltd.
Sk Biopharmaceuticals Co., Ltd. is a public company listed under the ticker 326030 on the Korean market. The company has a market capitalization of approximately 4.49 billion USD. Sk Biopharmaceuticals focuses on the development and commercialization of innovative biopharmaceutical products.
- Ticker
- 326030:KRX
- Asset type
- Stock
- Market cap
- $4.49B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW